chalcone has been researched along with Bone Loss, Osteoclastic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Cirelli, G; de Assis, LR; de Godoi, MA; de Matos, IAF; Fernandes, NAR; GuimarĂ£es-Stabili, MR; Regasini, LO; Rossa Junior, C | 1 |
Camilli, AC; Fernandes, NAR; GuimarĂ£es-Stabili, MR; Maldonado, LAG; Molon, RS; Pacheco, CGP; Regasini, LO; Ribeiro de Assis, L; Rossa Junior, C; Silva, AF; Spolidorio, LC | 1 |
Jiang, J; Li, L; Liu, L; Pan, W; Tao, W; Yu, Q; Zhang, D | 1 |
3 other study(ies) available for chalcone and Bone Loss, Osteoclastic
Article | Year |
---|---|
Chalcone T4 Inhibits RANKL-Induced Osteoclastogenesis and Stimulates Osteogenesis In Vitro.
Topics: Animals; Bone Resorption; Cell Differentiation; Chalcone; Chalcones; Core Binding Factor Alpha 1 Subunit; Matrix Metalloproteinase 9; Mice; NF-kappa B; NFATC Transcription Factors; Osteoclasts; Osteogenesis; Proto-Oncogene Proteins c-akt; RANK Ligand | 2023 |
Chalcone T4, a novel chalconic compound, inhibits inflammatory bone resorption in vivo and suppresses osteoclastogenesis in vitro.
Topics: Alveolar Bone Loss; Animals; Bone Resorption; Cell Differentiation; Chalcone; Chalcones; Mice; Osteoclasts; Osteogenesis; RANK Ligand; Rats | 2021 |
Hydroxysafflor Yellow A Promoted Bone Mineralization and Inhibited Bone Resorption Which Reversed Glucocorticoids-Induced Osteoporosis.
Topics: Animals; Bone and Bones; Bone Density; Bone Resorption; Calcification, Physiologic; Chalcone; Glucocorticoids; Humans; Osteoblasts; Osteoporosis; Quinones; Zebrafish | 2018 |